Hutchens & Kramer Investment Management Group’s AbbVie ABBV Stock Holding History

Hutchens & Kramer Investment Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248K	Buy	985 +6	+0.6%	+$1.29K	0.07%	139
2026 Q1	$213K	Sell	979 -1,029	-51%	-$228K	0.07%	141
2025 Q4	$459K	Sell	2,008 -2	-0.1%	-$456	0.16%	86
2025 Q3	$465K	Buy	2,010 +38	+2%	+$7.74K	0.18%	82
2025 Q2	$375K	Sell	1,972 -67	-3%	-$12.5K	0.17%	90
2025 Q1	$427K	Sell	2,039 -434	-18%	-$84.4K	0.24%	76
2024 Q4	$439K	Buy	2,473 +524	+27%	+$96.3K	0.24%	76
2024 Q3	$384K	Buy	1,949 +126	+7%	+$23.5K	0.21%	85
2024 Q2	$311K	Sell	1,823 -2	-0.1%	-$331	0.17%	99
2024 Q1	$330K	Buy	1,825 +73	+4%	+$12.6K	0.2%	88
2023 Q4	$272K	Buy	+1,752	New	+$255K	0.19%	91

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Hutchens & Kramer Investment Management Group's ABBV Position: Q2 2026 in Review

Hutchens & Kramer Investment Management Group increased its AbbVie (ABBV) stake by 0.61% in Q2 2026, buying an estimated $1.29K and bringing the position to 985 shares worth $248K. The position accounts for 0.07% of the portfolio, ranked #139.

Hutchens & Kramer Investment Management Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $465K in Q3 2025. 1,514 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Hutchens & Kramer Investment Management Group held 985 shares of AbbVie worth $248K as of Q2 2026.
Hutchens & Kramer Investment Management Group bought 6 AbbVie shares in Q2 2026, an estimated $1.29K.
AbbVie made up 0.07% of Hutchens & Kramer Investment Management Group's portfolio in Q2 2026, its #139 holding.
Hutchens & Kramer Investment Management Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Hutchens & Kramer Investment Management Group's AbbVie position peaked at $465K in Q3 2025.
1,514 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hutchens & Kramer Investment Management Group's 13F filing for Q2 2026, filed 9 Jul 2026.